|ZFIN ID: ZDB-PUB-130610-19|
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.
TALE nuclease engineering and targeted genome modification
Shen, Y., Xiao, A., Huang, P., Wang, W.Y., Zhu, Z.Y., and Zhang, B.
|Source:||Yi chuan = Hereditas 35(4): 395-409 (Journal)|
|Registered Authors:||Huang, Peng, Shen, Yan, Xiao, An, Zhang, Bo|
|PubMed:||23659930 Full text @ Yi Chuan|
Shen, Y., Xiao, A., Huang, P., Wang, W.Y., Zhu, Z.Y., and Zhang, B. (2013) TALE nuclease engineering and targeted genome modification. Yi chuan = Hereditas. 35(4):395-409.
ABSTRACTArtificial designer nucleases targeting specific DNA sequences open up a new field for reverse genetics study. The rapid development of engineered endonucleases (EENs) enables targeted genome modification theoretically in any species. The construction of transcription activator-like effector nucleases (TALENs) is simpler with higher specificity and less toxicity than zinc-finger nucleases (ZFNs). Here, we summarized the recent progresses and prospects of TALEN technology, with an emphasis on its structure, function, and construction strategies, as well as a collection of species and genes that have been successfully modified by TALENs, especially the application in zebrafish.
ADDITIONAL INFORMATION No data available
ERRATA and NOTESArticle is in Chinese.